Go back to MDS Pharma Services home page

Home / Events / Zurich Symposium 2008

MDS Pharma Services recently hosted a symposium on Using Science and Experience to Maximise Your ROI in Biosimilars in Zurich on May 20, 2008. Attendees enjoyed the presentations and dynamic discussion that took place.

We have developed recorded webinars of the presentations for your review. Below are the list of the presentations, please click on the 'View Webinars' button to review these.

  • Introduction
    Todd Johnson, MD, MBA
    Senior Vice President
    Early Stage Development
    MDS Pharma Services
  • Immunogenicity: Considerations Pre and Post Marketing
    Marian Kelley
    MKelley Consulting LLC
  • Biosimilars: A Big but Challenging Opportunity
    Andreas Schmidt
    Director, Equity Research
    Merrill Lynch Capital Markets
  • Production and Quality Issues in Developing Biosimilar Recombinant Erythropoetin
    Xuming Shen, MD, MBA
    Licensing and Marketing Director
    Holygene European Representative Office
  • Regulatory Pathways for Approval in Europe and the United States
    Suzanne Sensabaugh, MS, MBA
    John Hopkins University
  • Clinical PK/PD Considerations
    David Goblot, BSc., DESS
    Principal PK Scientist
    Protocol Design and Development
    MDS Pharma Services
  • Immunogenicity Assay Method Development
    Chris Beaver, PhD
    Director, Ligand Binding Services
    MDS Pharma Services
  • Case Study: Alpheon
    Cornelia Ulm
    Head of RA & QA
    Biopartners GmbH


If you would like to further discuss any of the topics from the symposium, please contact us.


© 2009 MDS Pharma Services     |     Corporate Governance     |     Legal     |     Privacy     |     Site Map